Sex Tape May Have Triggered China's Major Crackdown On Drug Makers
This article was originally published in PharmAsia News
Executive Summary
China's major crackdown on drug companies suspected of paying bribes may have been triggered by a sex involving GlaxoSmithKline's U.K.-born chief executive in China that was sent to senior executives, including CEO Andrew Witty.